Non-tumorous liver tissue removed during surgery to resect hepatocellular carcinoma (HCC) is potentially a useful source of material from which cells, particularly liver progenitor/stem cells (LPCs), can be isolated to establish cell lines. The purpose of this study was to evaluate the applicability of the "plate-and-wait" method to derive LPCs from resections to remove HCC. Three independent non-tumorous liver samples from HCC resection and 3 samples from liver donors were used for LPC isolation. Staining for LPC markers, OV6, CK19, and EpCAM, in the above liver samples demonstrated staining in only 2 of the non-tumorous samples. We isolated 2 human liver epithelial cell lines (HLECs) from these 2 samples. These HLECs were positive for general stem cell markers CD133, EpCAM, and Oct4. They expressed the liver progenitor cell markers OV6, CK14, and M2PK but not CK19. They also expressed the hepatocellular markers albumin, CK8, CK18, HNF4-α, and the drug-metabolizing gene CYP3A4. These cells accumulated glycogen, indocyanine green, and synthesized urea. They produced colonies in soft agar that showed anchorage-independent growth and their tumorigenic status was confi rmed when they produced tumors following transfer to athymic nude mice. In contrast, the third nontumorous tissue and 3 normal liver samples did not produce cell lines. This study establishes a correlation between the presence of LPCs in the source liver tissue and the ability to derive cell lines from these tissues. The phenotypic similarities between the LPCs and the HLECs suggest that a precursor-product relationship may exist between the 2 cell types.
IntroductionT he principal treatment modality of end-stage liver disease is orthotopic liver transplantation. The paucity of available organs is driving research to seek alternative therapies. One approach is cell therapy, and the use of hepatocytes has been evaluated with limited success, partly due to their fragility that makes them diffi cult to isolate and store. Liver progenitor/stem cells (LPCs) offer the advantage of being extremely robust, rapidly propagated and able to generate both hepatocytes and cholangiocytes. LPCs offer a major therapeutic opportunity in fi elds as diverse as gene therapy, initiation of liver repair, and biological liver support systems. To realize this potential, it is necessary to identify suitable sources of LPCs, establish reproducible methods for their isolation, and defi ne conditions for their expansion and subsequent culture, differentiation, and maturation into functional hepatocytes and cholangiocytes.Several attempts have been made to isolate LPCs from diseased adult human liver [1][2][3][4][5][6]
ZHANG ET AL. 1278non-specifi c binding and intrinsic peroxidase activity, the sections were incubated with a primary monoclonal antibody overnight at 4°C. After washes, the sections were incubated with the secondary antibody (peroxidase-labeled; Bio-Rad, Hercules, CA) for 60 min. The staining reaction was developed with DAB substrate (DAKO, Glostrup, Denmark). Con...